Article Review: Theranostics using 89Zr 177Lu labeled antibody targeting erythropoietin producing hepatocellular A2 EphA2

Objectives Developed a theranostic approach using 89Zr/177Lu-labeled EphA2 monoclonal antibody (mAb) (clone 230-1). Demonstrated high tumor retention of [89Zr]Zr-/[177Lu]Lu-EphA2 mAb in HT-1080 (EphA2-expressing human fibrosarcoma) xenografts. Achie...